JP2023511382A5 - - Google Patents
Info
- Publication number
- JP2023511382A5 JP2023511382A5 JP2022544318A JP2022544318A JP2023511382A5 JP 2023511382 A5 JP2023511382 A5 JP 2023511382A5 JP 2022544318 A JP2022544318 A JP 2022544318A JP 2022544318 A JP2022544318 A JP 2022544318A JP 2023511382 A5 JP2023511382 A5 JP 2023511382A5
- Authority
- JP
- Japan
- Prior art keywords
- brain
- human
- human subject
- expression vector
- idua
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026019056A JP2026097826A (ja) | 2020-01-22 | 2026-02-09 | 完全ヒトグリコシル化ヒトα-L-イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062964351P | 2020-01-22 | 2020-01-22 | |
| US62/964,351 | 2020-01-22 | ||
| US202063086145P | 2020-10-01 | 2020-10-01 | |
| US63/086,145 | 2020-10-01 | ||
| PCT/US2021/014129 WO2021150570A1 (en) | 2020-01-22 | 2021-01-20 | Treatment of mucopolysaccharidosis i with fully-human glycosylated human alpha-l-iduronidase (idua) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026019056A Division JP2026097826A (ja) | 2020-01-22 | 2026-02-09 | 完全ヒトグリコシル化ヒトα-L-イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023511382A JP2023511382A (ja) | 2023-03-17 |
| JP2023511382A5 true JP2023511382A5 (cg-RX-API-DMAC7.html) | 2024-02-16 |
Family
ID=74592808
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022544318A Pending JP2023511382A (ja) | 2020-01-22 | 2021-01-20 | 完全ヒトグリコシル化ヒトα-L-イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療 |
| JP2026019056A Pending JP2026097826A (ja) | 2020-01-22 | 2026-02-09 | 完全ヒトグリコシル化ヒトα-L-イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026019056A Pending JP2026097826A (ja) | 2020-01-22 | 2026-02-09 | 完全ヒトグリコシル化ヒトα-L-イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230059395A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4093428A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023511382A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220131522A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021211416A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022014563A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3167685A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL294625A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021150570A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3068328A1 (en) | 2017-07-06 | 2019-01-10 | The Trustees Of The University Of Pennsylvania | Aav9-mediated gene therapy for treating mucopolysaccharidosis type i |
| EP3684938A1 (en) | 2017-09-22 | 2020-07-29 | The Trustees of the University of Pennsylvania | Gene therapy for treating mucopolysaccharidosis type ii |
| US20230088992A1 (en) * | 2020-01-29 | 2023-03-23 | Regenxbio Inc. | Treatment of mucopolysaccharidosis ii with recombinant human iduronate-2-sulfatase (ids) produced by human neural or glial cells |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596535B1 (en) | 1999-08-09 | 2003-07-22 | Targeted Genetics Corporation | Metabolically activated recombinant viral vectors and methods for the preparation and use |
| CN103589692B (zh) | 2001-11-13 | 2018-07-24 | 宾夕法尼亚大学托管会 | 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法 |
| DK2359869T3 (en) | 2001-12-17 | 2019-04-15 | Univ Pennsylvania | Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof |
| EP1668143B1 (en) | 2003-09-30 | 2013-03-20 | The Trustees of The University of Pennsylvania | Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| DE23193606T1 (de) | 2005-04-07 | 2024-02-15 | The Trustees Of The University Of Pennsylvania | Verfahren zur erhöhung der funktion eines aav-vektors |
| JP4495210B2 (ja) | 2005-06-09 | 2010-06-30 | パナソニック株式会社 | 振幅誤差補償装置及び直交度誤差補償装置 |
| US8734809B2 (en) | 2009-05-28 | 2014-05-27 | University Of Massachusetts | AAV's and uses thereof |
| US8927514B2 (en) | 2010-04-30 | 2015-01-06 | City Of Hope | Recombinant adeno-associated vectors for targeted treatment |
| US8628966B2 (en) | 2010-04-30 | 2014-01-14 | City Of Hope | CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer |
| US10738326B2 (en) | 2010-10-27 | 2020-08-11 | Jichi Medical University | Adeno-associated virus vector for gene transfer to nervous system cells |
| CA2826273C (en) | 2011-02-10 | 2021-11-02 | The University Of North Carolina At Chapel Hill | Viral vectors with modified transduction profiles and methods of making and using the same |
| DK3693025T3 (da) | 2011-04-22 | 2022-01-10 | Univ California | Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf |
| EP3795581A3 (en) | 2011-08-24 | 2021-06-09 | The Board of Trustees of the Leland Stanford Junior University | New avv capsid proteins for nucleic acid transfer |
| EP3470523A1 (en) | 2012-05-09 | 2019-04-17 | Oregon Health & Science University | Adeno associated virus plasmids and vectors |
| EP2970946A4 (en) | 2013-03-13 | 2016-09-07 | Philadelphia Children Hospital | ADENOASSOZED VIRUS VECTORS AND METHOD FOR USE THEREOF |
| EP3564379A1 (en) | 2013-09-13 | 2019-11-06 | California Institute of Technology | Selective recovery |
| HUE052676T2 (hu) | 2013-10-11 | 2021-05-28 | Massachusetts Eye & Ear Infirmary | Eljárások õsi vírusszekvenciák elõrejelzésére és alkalmazásaik |
| US10746742B2 (en) | 2014-04-25 | 2020-08-18 | Oregon Health & Science University | Methods of viral neutralizing antibody epitope mapping |
| MA43968A (fr) * | 2016-02-03 | 2018-12-12 | Univ Pennsylvania | Thérapie génique pour traiter la mucopolysaccharidose de type i |
| JP7042814B2 (ja) * | 2016-11-01 | 2022-03-28 | 日本光電工業株式会社 | 患者の頭部に配置されて当該患者の脳の皮質組織の脈動を測定するためのトランスデューサを含むシステム |
| IL309808B2 (en) * | 2016-11-15 | 2025-04-01 | Univ Minnesota | Method for improving neurological function in MPSI and MPSII and other neurological disorders |
| JP2020508289A (ja) * | 2017-01-31 | 2020-03-19 | レジェンクスバイオ インコーポレーテッド | 完全ヒトグリコシル化ヒトα−L−イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療 |
| CA3068328A1 (en) * | 2017-07-06 | 2019-01-10 | The Trustees Of The University Of Pennsylvania | Aav9-mediated gene therapy for treating mucopolysaccharidosis type i |
-
2021
- 2021-01-20 KR KR1020227025630A patent/KR20220131522A/ko active Pending
- 2021-01-20 IL IL294625A patent/IL294625A/en unknown
- 2021-01-20 EP EP21705055.8A patent/EP4093428A1/en active Pending
- 2021-01-20 CA CA3167685A patent/CA3167685A1/en active Pending
- 2021-01-20 BR BR112022014563A patent/BR112022014563A2/pt not_active Application Discontinuation
- 2021-01-20 US US17/792,960 patent/US20230059395A1/en active Pending
- 2021-01-20 AU AU2021211416A patent/AU2021211416A1/en not_active Abandoned
- 2021-01-20 JP JP2022544318A patent/JP2023511382A/ja active Pending
- 2021-01-20 WO PCT/US2021/014129 patent/WO2021150570A1/en not_active Ceased
-
2026
- 2026-02-09 JP JP2026019056A patent/JP2026097826A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7308000B2 (ja) | Vegf-aポリペプチドをコードする改変rnaを送達するための脂質ナノ粒子 | |
| Xu et al. | Rosuvastatin treatment activates JAK-STAT pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts | |
| JP2020508289A5 (cg-RX-API-DMAC7.html) | ||
| Vallières et al. | Influence of interleukin‐6 on neural activity and transcription of the gene encoding corticotrophin‐releasing factor in the rat brain: an effect depending upon the route of administration | |
| JP2024540994A5 (cg-RX-API-DMAC7.html) | ||
| Zhao et al. | Targeting l‐selectin lymphocytes to deliver immunosuppressive drug in lymph nodes for durable multiple sclerosis treatment | |
| Weinstock-Guttman et al. | Treatment of fulminant multiple sclerosis with intravenous cyclophosphamide | |
| JP6026659B2 (ja) | 神経成長因子が中高年男性の性機能低下症候群を治療するための薬物の調製における応用 | |
| JP2021531276A5 (cg-RX-API-DMAC7.html) | ||
| CN107250360B (zh) | c-Rel特异性siRNA及其用于防治自身免疫性银屑病的应用 | |
| JP2022537555A5 (cg-RX-API-DMAC7.html) | ||
| Segura-Ulate et al. | FTY720-derivatives do not induce FTY720-like lymphopenia | |
| CN115624543A (zh) | 治疗偏头痛的药物、药物组合物、其制备方法和制药用途 | |
| CN107260723B (zh) | 5Z-7-oxozeaenol在制备治疗自身免疫性脑脊髓炎药物中的应用 | |
| CN118924875A (zh) | 药物组合物在治疗偏头痛上的应用 | |
| WO2020227690A1 (en) | Methods of using lipid nanoparticles for delivering modified rna encoding a vegf-a polypeptide and pharmaceutical compositions comprising the same | |
| Uemura et al. | The protective effect of interleukin-11 on the cell death induced by X-ray irradiation in cultured intestinal epithelial cell | |
| CN112190708A (zh) | 趋化因子受体ccr6抑制剂在预防银屑病复发中的新应用 | |
| CN118634324B (zh) | GCA-NAb单克隆抗体在制备预防和/或治疗肺纤维化药物中的应用 | |
| US11299537B2 (en) | Methods for treatment of motor neuron diseases | |
| CN114984074B (zh) | 一种人参总蛋白的制备方法及其改善帕金森病的应用 | |
| Gul et al. | Safe, Rapid-Onset, and Sustained Biological Activity of IL-1beta Regulating Antibody XOMA 052 in Resistant Uveitis of Behçet’s Disease: Preliminary Results of a Pilot Trial | |
| US11617729B2 (en) | Uses of guanidine hydrochloride as a drug for treating cancers/tumors | |
| CN120392989A (zh) | 一种用于多发性硬化症治疗的耐受原疫苗及其制备方法和应用 | |
| CN102274194A (zh) | 一种含托烷司琼化合物的药物组合物及其制备方法 |